Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2025 Apr 14;15(1):12852.
doi: 10.1038/s41598-025-96331-w.

The impact of inflammatory bowel disease on dementia risk: a current systematic review and meta-analysis

Affiliations
Meta-Analysis

The impact of inflammatory bowel disease on dementia risk: a current systematic review and meta-analysis

Tzu-Rong Peng et al. Sci Rep. .

Abstract

Emerging evidence indicates that inflammatory bowel disease (IBD) and dementia may share underlying pathological mechanisms and risk factors. However, the association between a prior IBD diagnosis and the subsequent risk of dementia remains largely unexplored. We conducted a comprehensive search of PubMed, Embase, and the Cochrane Library up to February 4, 2025, without language restrictions. Two reviewers independently extracted data and evaluated methodological quality and risk of bias. Observational studies comparing dementia risk in IBD and non-IBD populations were included. Pooled effect estimates for odds ratios (OR) were calculated using random-effects models. A total of 10 population-based studies, involving 7,895,339 participants (269,387 with IBD), were included. Meta-analysis of eight studies showed a significant association between IBD and dementia risk (OR 1.17, 95% CI: 1.08-1.27, P = 0.0001). However, IBD was not associated with an increased risk of Alzheimer's disease (AD) (OR 1.15, 95% CI: 0.98-1.36, P = 0.09). Stratified analysis by IBD type revealed a positive association between both ulcerative colitis (UC) and Crohn's disease (CD) and dementia risk (UC: OR 1.15, 95% CI: 1.05-1.25, P = 0.002, I² = 81%; CD: OR 1.26, 95% CI: 1.11-1.43, P = 0.0003, I² = 53%). This study identifies a significant correlation between IBD and dementia, suggesting that IBD patients have an elevated risk of developing dementia. However, current evidence is insufficient to establish a causal relationship. Further research should explore whether effective IBD treatments can mitigate this risk and elucidate the underlying pathophysiological mechanisms connecting these conditions.

Keywords: Dementia; Inflammatory bowel disease; Meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow diagram for study selection. *Consider, if feasible to do so, reporting the number of records identified from each database or register searched (instead of the total number across all databases and/or registers). **If automation tools were used, indicate how many records were excluded by a human and how many were excluded by an automation tool.
Fig. 2
Fig. 2
Forest plot for the risk of dementia in patients with inflammatory bowel disease.
Fig. 3
Fig. 3
Forest plot for the risk of Alzheimer’s disease in patients with inflammatory bowel disease.
Fig. 4
Fig. 4
Analysis of effect estimates based on study design for the risk of dementia in patients with inflammatory bowel disease.
Fig. 5
Fig. 5
Forest plot for the risk of dementia in patients with ulcerative colitis.
Fig. 6
Fig. 6
Forest plot for the risk of dementia in patients with Crohn’s disease.
Fig. 7
Fig. 7
Funnel plot of Odds Ratio vs. Standard Error for log Odds Ratio using a random effect model to evaluate publication bias for the risk of dementia in patients with inflammatory bowel disease.

References

    1. Chang, S., Murphy, M. & Malter, L. A review of available medical therapies to treat Moderate-to-Severe inflammatory bowel disease. Am. J. Gastroenterol.119 (1), 55–80 (2024). - PubMed
    1. Di’Narzo, A. F. et al. Integrative analysis of the inflammatory bowel disease serum metabolome improves our Understanding of genetic etiology and points to novel putative therapeutic targets. Gastroenterology162 (3), 828–843e11 (2022). - PMC - PubMed
    1. Fakhoury, M., Negrulj, R., Mooranian, A. & Al-Salami, H. Inflammatory bowel disease: clinical aspects and treatments. J. Inflamm. Res.7, 113–120 (2014). - PMC - PubMed
    1. Jiang, C., Li, G., Huang, P., Liu, Z. & Zhao, B. The gut microbiota and Alzheimer’s disease. J. Alzheimers Dis.58 (1), 1–15 (2017). - PubMed
    1. Wu, S. C., Cao, Z. S., Chang, K. M. & Juang, J. L. Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in drosophila. Nat. Commun.8 (1), 24 (2017). - PMC - PubMed

MeSH terms

LinkOut - more resources